Position in BCRX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$47,680
+$2,289 QoQ
Shares Held
4,768
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#262
of 316 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ASSETMARK, INC holds $375,029,634 across 23 Drug Manufacturers - Specialty & Generic names. BCRX ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
624,068 | $338,138,764 | |
| 2 | ZTS |
Zoetis Inc.
|
282,029 | $20,266,603 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
314,687 | $5,044,432 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
16,414 | $2,766,415 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
81,250 | $2,752,750 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
49,713 | $2,312,151 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
68,590 | $1,384,146 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
12,110 | $1,343,483 |
All Filings in BCRX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,680 | 4,768 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $45,391 | 4,768 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $37,190 | 4,768 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $27,498 | 3,623 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $30,867 | 3,445 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $25,837 | 3,445 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $25,906 | 3,445 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $26,182 | 3,445 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $21,290 | 3,445 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $17,500 | 3,445 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $11,680 | 1,950 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $13,806 | 1,950 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $13,728 | 1,950 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $16,263 | 1,950 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $17,220 | 1,500 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $12,978 | 1,030 | Shares | Sole | 2022-11-01 | |
| 2021-12-31 | $1,329 | 96 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||